Clinical Trials Directory

Trials / Completed

CompletedNCT02619539

Shock Index To DEtect Low Plasma Fibrinogen In Trauma (SIDE)

Status
Completed
Phase
Study type
Observational
Enrollment
280 (actual)
Sponsor
Masaryk Hospital Krajská zdravotní a.s. · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Shock-index is potentially an easy tool to estimate the risk of hypofibrinogenemia without the need to perform other potentially time consuming investigations.

Detailed description

Hypofibrinogenemia is common in severe trauma and below the threshold of 2.3 g/l is associated with increased mortality. Although guidelines for management of the trauma induced coagulopathy does not recommend any specific timing of fibrinogen substitution, several papers suggest that early substitution might be associated with improved outcome. Laboratory measurement of plasma fibrinogen level, thromboelastometry and/or its estimation based on base excess, hemoglobin level, Injury Severity Score or combinations require diagnostic procedures that are associated with with a certain time delay and prolongs the time to fibrinogen substitution.

Conditions

Interventions

TypeNameDescription
PROCEDUREplasma fibrinogen measurementplasma fibrinogen measurement

Timeline

Start date
2016-01-01
Primary completion
2017-02-28
Completion
2017-02-28
First posted
2015-12-02
Last updated
2017-03-24

Locations

2 sites across 1 country: Czechia

Source: ClinicalTrials.gov record NCT02619539. Inclusion in this directory is not an endorsement.

Shock Index To DEtect Low Plasma Fibrinogen In Trauma (SIDE) (NCT02619539) · Clinical Trials Directory